The Clonogenic Growth of Cells Derived From Bladder Barbotage in Patients With Transitional Cell Carcinoma of the Bladder: A Preliminary Report
- 1 April 1982
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 127 (4) , 668-670
- https://doi.org/10.1016/s0022-5347(17)53985-3
Abstract
Tumor cells obtained from bladder washings in 41 patients with transitional cell carcinoma of the bladder and 15 control subjects were analyzed for their ability to produce cluster and/or colony formation in a tumor stem cell assay. In vitro cell growth was correlated with the presence of tumor at the time of bladder washing, tumor grade and treatment status. Of 34 bladder washings from patients with biopsy-proved transitional cell carcinoma 88% produced cluster and/or colony formation. Specimens from patients not currently receiving intravesical chemotherapy at the time of bladder barbotage produced colonies in 54% of the cases, compared to 25% from patients receiving therapeutic or maintenance therapy. Higher grade tumors produced more viable cells at bladder barbotage but clonal growth rates were independent of histologic grade. Apparently, bladder barbotage may serve as a source of cells for chemotherapeutic drug testing in patients with transitional cell carcinoma of the bladder. Bladder washings also may be useful as a source of tumor cells for monitoring the in vivo growth potential of bladder cancer in the tumor stem cell assay.This publication has 9 references indexed in Scilit:
- Red Cell Surface Antigen and its Relationship to Survival of Patients with Transitional Cell Carcinoma of the BladderJournal of Urology, 1981
- A 10-Year Analysis of Chromosomes in Non-Invasive Papillary Carcinoma of the BladderJournal of Urology, 1981
- An in Vitro Clonal Assay for Bladder Cancer: Clinical Correlation with the Status of the Urothelium in 33 PatientsJournal of Urology, 1980
- The Pathology of Human Bladder CancerCancer, 1980
- „NORMAL” urothelium in patients with bladder cancer.A preliminary report from the national bladder cancer collaborative group aCancer, 1979
- Blood group isoantigen deletion in carcinomain situ of the urinary bladderCancer, 1979
- Quantitation of Differential Sensitivity of Human-Tumor Stem Cells to Anticancer DrugsNew England Journal of Medicine, 1978
- Tissue Blood-Group Antigens and Prognosis in Low Stage Transitional Cell Carcinoma of the BladderJournal of Urology, 1978
- Primary Bioassay of Human Myeloma Stem CellsJournal of Clinical Investigation, 1977